| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 79.193 | 112.582 | 98.936 | 94.802 | 122.894 | 150.532 | 145.203 | 173.683 | 180.747 |
| Total Income - EUR | - | 79.404 | 113.410 | 99.317 | 96.468 | 124.060 | 152.697 | 147.132 | 175.638 | 182.437 |
| Total Expenses - EUR | - | 37.469 | 72.366 | 73.835 | 72.778 | 76.391 | 77.444 | 102.857 | 113.561 | 131.296 |
| Gross Profit/Loss - EUR | - | 41.935 | 41.044 | 25.482 | 23.690 | 47.670 | 75.253 | 44.275 | 62.077 | 51.141 |
| Net Profit/Loss - EUR | - | 39.558 | 37.657 | 22.514 | 20.820 | 44.205 | 70.720 | 40.833 | 60.339 | 47.356 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pharma Euro Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 114 | 2.600 | 2.159 | 1.331 | 1.853 | 7.594 | 18.322 | 55.092 | 43.182 |
| Current Assets | - | 43.198 | 81.004 | 77.559 | 78.131 | 91.861 | 151.535 | 97.381 | 99.974 | 131.676 |
| Inventories | - | 1.925 | 0 | 250 | 0 | 1.305 | 0 | 2.136 | 0 | 0 |
| Receivables | - | 4.271 | 18.064 | 17.779 | 26.725 | 38.247 | 17.097 | 5.231 | 17.298 | 24.036 |
| Cash | - | 37.002 | 62.940 | 59.530 | 51.405 | 52.308 | 134.438 | 90.013 | 82.675 | 107.640 |
| Shareholders Funds | - | 39.603 | 76.590 | 76.209 | 70.251 | 82.114 | 151.013 | 98.479 | 137.903 | 160.273 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.709 | 7.014 | 3.514 | 9.216 | 11.604 | 8.120 | 17.262 | 17.753 | 14.652 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Pharma Euro Consult Srl